SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T103. A total of 38 filers reported holding SAB BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,936 | -24.1% | 47,518 | 0.0% | 0.00% | – |
| Q2 2023 | $39,440 | +88.6% | 47,518 | 0.0% | 0.00% | – |
| Q1 2023 | $20,908 | -26.9% | 47,518 | -2.1% | 0.00% | – |
| Q4 2022 | $28,620 | -13.3% | 48,518 | +2.1% | 0.00% | – |
| Q3 2022 | $33,000 | -50.7% | 47,518 | +2.1% | 0.00% | – |
| Q2 2022 | $67,000 | -61.7% | 46,528 | 0.0% | 0.00% | – |
| Q1 2022 | $175,000 | – | 46,528 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First PREMIER Bank | 807,535 | $509 | 0.16% |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 192,027 | $120,977 | 0.02% |
| LGL PARTNERS, LLC | 23,000 | $14,490 | 0.00% |
| Strategic Financial Concepts, LLC | 15,027 | $9,467 | 0.00% |
| Elgethun Capital Management | 9,935 | $6,358 | 0.00% |
| PATHSTONE FAMILY OFFICE, LLC | 506,513 | $319,103 | 0.00% |
| PEAPACK GLADSTONE FINANCIAL CORP | 52,296 | $33 | 0.00% |
| FIRST MANHATTAN CO. LLC. | 277,777 | $174,999 | 0.00% |
| Gs Investments, Inc. | 2,000 | $1,260 | 0.00% |
| Nadler Financial Group, Inc. | 13,750 | $8,663 | 0.00% |